Revisiting the Association between Estrogen Exposure and Parkinson’s Disease: A Fox Insight Analysis
Objective: To evaluate the association between markers of lifetime estrogen exposure and Parkinson’s Disease (PD) in a large digital cohort of postmenopausal women. Background: The…Exploring the Neuroprotective Potential of Raloxifene and Fulvestrant Against Haloperidol Induced Parkinson Disease; Insights into GPR30/PI3k/Akt/Nrf2 Signaling Pathways
Objective: To investigate the neuroprotective effect of raloxifene and fulvestrant on behavioral, biochemical, neurochemical, and molecular alterations in a haloperidol-induced animal model of Tardive dyskinesia.To…Women with Parkinson’s disease: exploring the occurrence of hormone-related symptom fluctuations and associated care
Objective: To explore the occurrence of hormone-related symptom fluctuations and associated care in women with Parkinson’s disease (PD). Background: Pre- and (peri)menopausal women with PD…www.PregSpark.com, introducing the International PregnancieS and Parkinson’s Registry
Objective: To introduce the International PregnancieS and Parkinson’s Registry (www.PregSpark.com). Background: Pregnancy in Parkinson’s disease (PD) is rare, but with PD being the fastest growing…Pregnancy and delivery in women with Parkinson’s disease: A case series
Objective: To explore pregnancy, delivery, birth outcomes and disease course throughout pregnancy in women with Early Onset Parkinson’s disease (EOPD) who underwent pregnancy after onset…Women and PD: experienced changes in parkinson symptoms after menopause
Objective: This study aimed to gain insight into changes in parkinson (PD) symptoms experienced by women after menopause. Background: Although most people are diagnosed with…Reproductive life factors and sex hormones in post-menopausal female patients with Parkinson’s Disease
Objective: To deepen into sex-dependent mechanisms of Parkinson’s disease (PD) by analyzing the relationships between reproductive life factors, sex hormones, clinical features, and CSF biomarkers…Estrogen and progesterone influence membrane functions and glucose transporter expression in synaptosomes of different age groups of naturally menopausal rats
Objective: The objective of this study was to determine the effect of 17 β-estradiol (E2) and progesterone (P4) on the activities of Na+ K+ ATPase, monoamine…Premenstrual worsening of UPDRS motor scale in women affected by Parkinson’s Disease
Objective: The role of estrogen in dopaminergic pathways and the premenstrual worsening of parkinsonian symptoms. Background: Female sex hormones, during the menstrual cycle, could influence…Estrogen derivatives and hydrogen peroxide as promising biomarkers in parkinson’s disease-preliminary results
Objective: The study aimed to identify biomarkers of early-stage neurodegeneration in Parkinson’s disease (PD). Background: The currently available diagnostic clinical criteria for PD enable diagnosis…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.